Erratum: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study (BMJ (Online) (2010) 340 (c1040) DOI: 10.1136/bmj.c1040);HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study

BMJ (Online)

Volumn 340, Issue 7752, 2010, Pages 905-

  Gök, Murat ^a   Heideman, Daniëlle A M ^a   Van Kemenade, Folkert J ^a   Berkhof, Johannes ^a   Rozendaal, Lawrence ^a   Spruyt, Johan W M ^a   Voorhorst, Feja ^a   Beliën, Jeroen A M ^a   Babović, Milena ^b   Snijders, Peter J F ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Regional Screening Organisation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SELF EXAMINATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL LAVAGE; VIRUS DIAGNOSIS; WART VIRUS;

EID: 84881313760     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i2823     Document Type: Erratum

References (28)

1. Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007;120:1505-1510 (Pubitemid 46355385)
2. Raab SS, Grzybicki DM, Zarbo RJ, Jensen C, Geyer SJ, Janosky JE, et al. Frequency and outcome of cervical cancer prevention failures in the United States. Am J Clin Pathol 2007;128:817-824 (Pubitemid 350133994)
3. Sawaya GF, Grimes DA. New technologies in cervical cytology screening: a word of caution. Obstet Gynecol 1999;94:307-310
4. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88:2283-2289
5. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-256
6. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93.
7. Wikstrom I, Stenvall H, Wilander E. Attitudes to self-sampling of vaginal smear forhuman papilloma virus analysisamongwomen not attending organized cytological screening. Acta Obstet Gynecol Scand 2007;86:720-725 (Pubitemid 46801783)
8. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-86
9. Brink AA, Meijer CJ, Wiegerinck MA, Nieboer TE, Kruitwagen RF, van Kemenade F, et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by twomethods, with comparison of a novel self-sampling device to a conventional endocervical brush. J ClinMicrobiol 2006;44:2518-2523
10. Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004;57:388-393
11. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year followup of a randomised controlled implementation trial. Lancet 2007;370:1764-1772
12. Hopman EH, Rozendaal L, Voorhorst FJ, Walboomers JM, Kenemans P, Helmerhorst TJ. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJOG 2000;107:600-604
13. Hopman EH, Voorhorst FJ, Kenemans P, Meyer CJ, Helmerhorst TJ. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 1995;58:206-209
14. Anderson MC. Premalignant and malignant squamous lesions of the cervix. In: Fox H, Wells M, Haines M, Taylor C, eds. Obstetrical and gynaecological pathology. Churchill Livingstone, 1995:292-297
15. Wright TC. Precancerous lesions of the cervix. Blaustein's pathology of the female genital tract. 4th ed. Springer Verlag, 1995:248-257
16. Rebolj M, van Ballegooijen M, Berkers LM, Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007;120:806-812
17. Hanselaar AG. Criteria for organized cervical screening programs. Special emphasis on the Netherlands program. Acta Cytol 2002;46:619-629
18. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007;29:19-24.
19. Bekkers RLM, Hanselaar AGJM, Melchers WJG, Van Westering RP, Boonstra H, Massuger LFAG. [Wait-and-see policy versus loop excision after two consecutive Pap 2 cervical smears: fewer interventions and an equivalent outcome over time; no real contribution to be expected from high-risk human papillomavirus detection.] Ned Tijdschr Geneeskd 2003;147:302-306
20. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002;11:1394-1399 (Pubitemid 35340375)
21. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, et al. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 2007;34:849-855
22. Hesselink AT, Bulkmans NW, Berkhof J, Lorincz AT, Meijer CJ, Snijders PJ. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol 2006;44:3680-3685
23. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006;82:337-339
24. Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C, et al. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. Int J Gynecol Cancer 2007;17:615-622
25. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-555
26. Bulk S, Bulkmans NW, Berkhof J, Rozendaal L, Boeke AJ, Verheijen RH, et al. Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. Int J Cancer 2007;121:361-367
27. Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design,methods and baseline data of 44,102 women. Int J Cancer 2004;110:94-101.
28. Overmeer RM, Henken FE, Snijders PJ, Claassen-Kramer D, Berkhof J, Helmerhorst TJ, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol 2008;215:388-397